7.01 USD
▲+0.34+6.37%
2026-08-03
市值
$86.81M
市盈率
—
EPS
-0.81
股息率
—
52 周区间
2.20 – 9.33
成交量
159.70K
Beta
1.42
目标价
11.00
52W 低 2.2052W 高 9.33
价格走势
公司简介
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation di...